|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 19/00 | |
| C12N 15/62 | |||
| C12N 15/63 | |||
| A61K 38/19 | |||
| A61P 25/00 | |||
| C07K 14/535 | |||
| A61K 38/18 |
| (11) | Number of the document | 3121198 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16185991.3 |
| Date of filing the European patent application | 2011-05-25 | |
| (97) | Date of publication of the European application | 2017-01-25 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-14 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201010181623 | 2010-05-25 | CN |
| (72) |
YAN, Xiaoqiang, CN
HUANG, Zhihua, CN
YANG, Hongzhou, CN
SUN, Bill N.C., CN
HUANG, Yuliang, CN
|
| (73) |
Generon (Shanghai) Corporation Ltd.,
Suite 307 1011 Ha Lei Road China (Shanghai) Pilot Free Trade Zone, Shanghai 201203,
CN
|
| (54) | RECOMBINANT HUMAN G-CSF DIMER AND USE THEREOF FOR THE TREATMENT OF NEUROLOGICAL DISEASES |
| RECOMBINANT HUMAN G-CSF DIMER AND USE THEREOF FOR THE TREATMENT OF NEUROLOGICAL DISEASES |